Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (GZPHF)
2.34
0.00 (0.00%)
USD |
OTCM |
Sep 03, 16:00
Guangzhou Baiyunshan Pharmaceutical Holdings Gross Profit Margin (Quarterly) : 12.63% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.63% |
| March 31, 2026 | 19.60% |
| December 31, 2025 | 10.01% |
| September 30, 2025 | 15.28% |
| June 30, 2025 | 14.94% |
| March 31, 2025 | 20.14% |
| December 31, 2024 | 11.90% |
| September 30, 2024 | 14.43% |
| June 30, 2024 | 13.81% |
| March 31, 2024 | 21.08% |
| December 31, 2023 | 13.12% |
| September 30, 2023 | 17.15% |
| June 30, 2023 | 16.72% |
| March 31, 2023 | 22.18% |
| December 31, 2022 | 13.92% |
| September 30, 2022 | 16.62% |
| June 30, 2022 | 16.07% |
| March 31, 2022 | 22.49% |
| December 31, 2021 | 14.30% |
| September 30, 2021 | 17.85% |
| June 30, 2021 | 17.69% |
| March 31, 2021 | 21.42% |
| December 31, 2020 | 7.76% |
| September 30, 2020 | 17.67% |
| June 30, 2020 | 15.85% |
| Date | Value |
|---|---|
| March 31, 2020 | 20.85% |
| December 31, 2019 | 12.22% |
| September 30, 2019 | 19.48% |
| June 30, 2019 | 18.24% |
| March 31, 2019 | 23.94% |
| December 31, 2018 | 18.74% |
| September 30, 2018 | 18.08% |
| June 30, 2018 | 25.84% |
| March 31, 2018 | 37.31% |
| December 31, 2017 | 39.33% |
| September 30, 2017 | 34.94% |
| June 30, 2017 | 34.63% |
| March 31, 2017 | 38.31% |
| December 31, 2016 | 18.10% |
| September 30, 2016 | 32.07% |
| June 30, 2016 | 35.16% |
| March 31, 2016 | 37.98% |
| December 31, 2015 | 34.40% |
| September 30, 2015 | 34.46% |
| June 30, 2015 | 37.30% |
| March 31, 2015 | 34.32% |
| December 31, 2014 | 33.01% |
| September 30, 2014 | 33.32% |
| June 30, 2014 | 34.94% |
| March 31, 2014 | 33.01% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Sinopharm Group Co., Ltd. | -- |
| PomDoctor Ltd. | -- |
| Cencora, Inc. | 3.93% |
| Cardinal Health, Inc. | 3.87% |
| McKesson Corp. | 3.31% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 6.53% |
| Return on Assets | 3.10% |
| Return on Invested Capital | 4.25% |
| Profit Margin (Quarterly) | 1.78% |
| Operating Margin (Quarterly) | 2.16% |
| Return on Net Operating Assets | 5.40% |